Meridian Life Sciences

What Meridian Life Sciences does

Meridian Life Sciences is a B2B manufacturer of diagnostic raw materials operating as the Life Science division of Meridian Bioscience (NASDAQ: VIVO). The company develops, manufactures, and distributes two core product lines: (1) Molecular Reagents & Services, including liquid ambient-stable master mixes, specimen-specific inhibitor-tolerant master mixes, Lyo-Ready and air-dryable master mixes, qPCR/RT-qPCR master mixes, isothermal amplification reagents, enzymes, NGS enzymes, nucleotides, reaction buffers, and custom molecular services; and (2) Antibodies, Antigens, Blockers & Services, comprising over 3,000 antigens and antibodies spanning more than 500 disease areas. All products are manufactured under ISO 13485 regulations.

The company sells to diagnostic manufacturers across four verticals — human diagnostics, veterinary diagnostics, plant health, and environmental testing — as well as to molecular companies and antibody companies. Its commercial model is sales-led direct B2B, with a quote-based, non-publicly-disclosed pricing structure and a global customer footprint. Go-to-market is supported by a multi-channel content engine (technical blog, webinars, trade shows including NextGen DX/AMP/ADLM/I-MDX, quarterly newsletter, social media) and a reference tool (Pairs Table) for assay developers.

The business model is one-time reagent sales (raw materials and critical components) rather than licensing or subscription revenue. The company pursues custom antibody and recombinant protein manufacturing services (notably expanded via the April 2022 acquisition of EUPROTEIN Inc.) as a higher-touch revenue stream alongside its catalog business. Strategic positioning emphasizes first-to-market product development for emerging pathogens, with documented supply of novel antigens and antibodies for Zika and SARS-CoV-2.

Name

Meridian Life Sciences

Legal name

Meridian Bioscience Inc.

Website

https://meridianlifescience.com

Company type

Public

Founded year

1981

Operating status

Operating

Headcount range

11–50 employees

Short description

Meridian Life Sciences is a B2B manufacturer of molecular biology reagents and immunological reagents (3,000+ antigens/antibodies across 500+ diseases) sold as raw materials and custom services to diagnostic manufacturers worldwide under ISO 13485.

Ownership category

akta.pro rank

Product category

Diagnostic Reagents and Assay Raw Materials

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industries

Raw Materials & Critical Reagents Supply (Media/Resins/Cytokines) (HLAGAGAI), Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB), Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)

Keywords

• Diagnostic reagents
• Molecular biology reagents
• Antibodies and antigens
• Recombinant proteins
• Assay development supplies

Headquarters

HQ city

Memphis

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Life Science Reagent Sales: Sale of molecular biology reagents including master mixes, enzymes, nucleotides, and immunological reagents including antibodies, antigens, and blockers to diagnostic manufacturers. Products are sold as raw materials and critical components for assay development.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Meridian Life Sciences develops, manufactures, and distributes critical raw materials and reagents for diagnostic assay developers worldwide. Its core offering is organized into two product lines: molecular biology reagents (qPCR/RT-qPCR master mixes, isothermal amplification reagents, enzymes, NGS enzymes, nucleotides, reaction buffers, RNase inhibitor, DNA/RNA extraction controls, and custom molecular services) and a large immunological portfolio (antibodies, antigens, blockers, and immunoglobulins) covering more than 3,000 antigens and antibodies across 500+ disease areas for human, veterinary, plant, and environmental diagnostic applications.

Product overview

Meridian Life Sciences is a fully integrated life science company operating as the Life Science division of Meridian Bioscience. It develops, manufactures, and distributes a broad portfolio of diagnostic products and critical raw materials organized into two core product lines: (1) Molecular Reagents & Services — including qPCR/RT-qPCR master mixes, isothermal amplification reagents, enzymes, NGS enzymes, nucleotides, and custom molecular services; and (2) Antibodies, Antigens, Blockers & Services — spanning over 3,000 antigens and antibodies across more than 500 disease areas. The company also operates a Diagnostics division with multiple platform brands including Revogene and Alethia (molecular), BreathID Hp Lab/Smart/Hp (urea breath), Curian and Immunocard STAT/Premier/Tru/Merifluor (immunoassay), and LeadCare (blood chemistry/lead detection), all supported by Para-Pak transport and stain products. All products are manufactured under ISO 13485 regulations, with the Meridian Bioline sub-brand trusted by molecular companies, antibody companies, and diagnostic manufacturers worldwide.

Differentiator

Problem solved

Functional benefit

Brands

• Revogene: Molecular diagnostic platform
• Alethia
• BreathID
• Curian
• Immunocard STAT
• Premier
• Tru
• Merifluor
• LeadCare
• Para-Pak

Products and services

• Molecular Reagents & Services

Quantifiable outcome

• Supplied novel antigens and antibodies for emerging pathogens including Zika and SARS-CoV-2

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• EUPROTEIN Inc.coreStrategic or Co-development Partner · 30 April 2022Meridian Bioscience acquired substantially all assets of EUPROTEIN Inc. on April 30, 2022. The acquisition aimed to expand Meridian's recombinant protein capabilities and accelerate its pipeline of immunological reagents. EUPROTEIN specialized in high-quality bioresearch reagents, primarily focusing on proteins and monoclonal antibodies.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• GenScript: Custom antibody and recombinant protein manufacturer serving IVD and research customers, directly overlapping with Meridian's custom antibody/protein manufacturing services and immunological reagent business.
• SeraCare (now part of LGC Clinical Diagnostics): Supplier of immunoassay reagents, antigens, antibodies, and VLP/process controls to IVD assay developers — a tight functional fit with Meridian's antigen/antibody catalog and VLP control offerings.
• Promega Corporation: Mid-sized, integrated life science tools supplier offering master mixes, enzymes, antibodies, and IVD/OEM raw materials with a similar focus on diagnostic manufacturer customers. Closely comparable in scale, business model, and product overlap.
• LGC Group (LGC Biosearch Technologies): Supplies oligonucleotides, qPCR reagents, antibodies, and diagnostic raw materials with a portfolio analogous to Meridian's molecular and immunological reagent offering, including custom manufacturing.

Broad incumbents

• QIAGEN: Provider of sample technologies, qPCR enzymes, and IVD component solutions used by molecular diagnostic manufacturers. Comparable to Meridian's molecular reagent business, including master mixes and enzymes.
• MilliporeSigma (Merck KGaA Life Science): Operates the Sigma-Aldrich and Millipore portfolios covering antibodies, enzymes, nucleotides, and molecular biology reagents. A direct competitor in supplying antibodies, antigens, and qPCR-grade reagents to assay developers worldwide.
• Thermo Fisher Scientific: Largest life science tools supplier with a broad antibody, reagent, and molecular biology portfolio (e.g., Invitrogen, Thermo Scientific brands). Directly comparable as a supplier of qPCR master mixes, enzymes, antibodies, and assay raw materials to diagnostic manufacturers.
• PerkinElmer (now Revvity): Life science and diagnostics company with overlapping reagent, immunoassay, and molecular raw material offerings, including custom antibody and protein capabilities serving IVD manufacturers.
• Bio-Rad Laboratories: Diversified diagnostics and life science research company with overlapping offerings in immunoassay reagents, antibodies, controls, and qPCR reagents for IVD manufacturers. Comparable as a B2B supplier of critical raw materials and assay components.

Emerging players

• Diagnostic Biochips (now part of various) / VLP Controls peers: The Native Antigen Company is a niche reagent provider specializing in high-quality antigens and diagnostic raw materials for infectious disease, comparable to Meridian's disease-area antigen portfolio.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xtwitter.com/meridian_bio
• YouTubeyoutube.com/@meridianbioscience/featured
• Facebookfacebook.com/MeridianBioscience
• LinkedInlinkedin.com/company/meridian-life-science-inc.
• Instagraminstagram.com/meridianbioscience

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Meridian Life Sciences